Last reviewed · How we verify

intralesional injection of 5- Fluorouracil

Zagazig University · Phase 1 active Small molecule Quality 0/100

intralesional injection of 5- Fluorouracil is a Small molecule drug developed by Zagazig University. It is currently in Phase 1 development.

At a glance

Generic nameintralesional injection of 5- Fluorouracil
SponsorZagazig University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about intralesional injection of 5- Fluorouracil

What is intralesional injection of 5- Fluorouracil?

intralesional injection of 5- Fluorouracil is a Small molecule drug developed by Zagazig University.

Who makes intralesional injection of 5- Fluorouracil?

intralesional injection of 5- Fluorouracil is developed by Zagazig University (see full Zagazig University pipeline at /company/zagazig-university).

What development phase is intralesional injection of 5- Fluorouracil in?

intralesional injection of 5- Fluorouracil is in Phase 1.

Related